Iterum Therapeutics Plc (ITRM) Tops Q3 EPS by 58c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q3 EPS of ($0.30), $0.58 better than the analyst estimate of ($0.88).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Wall Street scrambles to lift Micron price targets ahead of earnings
• HCB shareholders approve Independent Bank's acquisition deal